Found: 148
Select item for more details and to access through your institution.
Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0298254
- By:
- Publication type:
- Article
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design.
- Published in:
- American Journal of Epidemiology, 2024, v. 193, n. 6, p. 883, doi. 10.1093/aje/kwad239
- By:
- Publication type:
- Article
The impact of COVID‐19 on the clinical course and outcome of patients with cirrhosis: An observational study.
- Published in:
- Health Science Reports, 2024, v. 7, n. 6, p. 1, doi. 10.1002/hsr2.2207
- By:
- Publication type:
- Article
Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0302629
- By:
- Publication type:
- Article
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1363045
- By:
- Publication type:
- Article
Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 147, doi. 10.1093/infdis/jiad393
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study.
- Published in:
- Influenza & Other Respiratory Viruses, 2023, v. 17, n. 11, p. 1, doi. 10.1111/irv.13224
- By:
- Publication type:
- Article
Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 8, p. 1033, doi. 10.1093/infdis/jiad195
- By:
- Publication type:
- Article
Development and characterization of letrozole-encapsulated polymeric beads for sustained release.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2023, v. 36, p. 1627, doi. 10.36721/PJPS.2023.36.5.SP.1627-1635.1
- By:
- Publication type:
- Article
RISK OF DEATH IN REMDESIVIR TREATED AND UNTREATED PATIENTS WITH COVID-19 INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 220
- By:
- Publication type:
- Article
NIRMATRELVIR USE AND HOSPITALIZATIONS OR DEATH IN INDIVIDUALS WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 224
- By:
- Publication type:
- Article
MOLNUPAVIR IN PREVIOUSLY UNINFECTED NONHOSPITALIZED PERSONS WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 225
- By:
- Publication type:
- Article
INCIDENCE OF NON-HEPATIC CANCERS IN HBV, HCV, AND HBV/HCV COINFECTED PERSONS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 244
- By:
- Publication type:
- Article
COVID-19 OUTCOME IN PATIENTS WITH AND WITHOUT CIRRHOSIS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 246
- By:
- Publication type:
- Article
IMMEDIATE AND CONTRIBUTORY CAUSES OF DEATH IN PATIENTS HOSPITALIZED WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 289
- By:
- Publication type:
- Article
Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018).
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad089
- By:
- Publication type:
- Article
Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012–2019.
- Published in:
- American Journal of Public Health, 2023, v. 113, n. 2, p. 162, doi. 10.2105/ajph.2022.307152
- By:
- Publication type:
- Article
Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35653-z
- By:
- Publication type:
- Article
Reply to Wirth et al.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case–Control Study.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 49, doi. 10.3390/vaccines11010049
- By:
- Publication type:
- Article
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 12, p. 2161, doi. 10.1093/cid/ciac328
- By:
- Publication type:
- Article
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2246604, doi. 10.1001/jamanetworkopen.2022.46604
- By:
- Publication type:
- Article
Polypharmacy and medical intensive care unit (MICU) admission and 10-year all-cause mortality risk among hospitalized patients with and without HIV.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0276769
- By:
- Publication type:
- Article
Variation in Clinical Treatment and Outcomes by Race Among US Veterans Hospitalized With COVID-19.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2238507, doi. 10.1001/jamanetworkopen.2022.38507
- By:
- Publication type:
- Article
COVID-19 Disease Severity in Persons Infected With Omicron BA.1 and BA.2 Sublineages and Association With Vaccination Status.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.984784
- By:
- Publication type:
- Article
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32363-4
- By:
- Publication type:
- Article
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271324
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e361, doi. 10.1093/cid/ciac275
- By:
- Publication type:
- Article
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e579, doi. 10.1093/cid/ciac178
- By:
- Publication type:
- Article
Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e617, doi. 10.1093/cid/ciac118
- By:
- Publication type:
- Article
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e849, doi. 10.1093/cid/ciab1023
- By:
- Publication type:
- Article
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e1188, doi. 10.1093/cid/ciab909
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 3871, doi. 10.2147/IDR.S360241
- By:
- Publication type:
- Article
Comparative COVID-19 Vaccine Effectiveness Over Time in Veterans.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac311
- By:
- Publication type:
- Article
Outer membrane vesicles as biomimetic vaccine carriers against infections and cancers.
- Published in:
- WIREs: Nanomedicine & Nanobiotechnology, 2022, v. 14, n. 4, p. 1, doi. 10.1002/wnan.1784
- By:
- Publication type:
- Article
COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31402-4
- By:
- Publication type:
- Article
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30895-3
- By:
- Publication type:
- Article
Endosomal Escape of Bioactives Deployed via Nanocarriers: Insights Into the Design of Polymeric Micelles.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 6, p. 1047, doi. 10.1007/s11095-022-03296-w
- By:
- Publication type:
- Article
SARS-CoV-2 Polymerase Chain Reaction Positivity Rates Among Evacuees From Afghanistan After Withdrawal of the Coalition Forces.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 5, p. e2213467, doi. 10.1001/jamanetworkopen.2022.13467
- By:
- Publication type:
- Article
SARS-CoV-2 Polymerase Chain Reaction Positivity Rates Among Evacuees From Afghanistan After Withdrawal of the Coalition Forces.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 5, p. 1, doi. 10.1001/jamanetworkopen.2022.13467
- By:
- Publication type:
- Article
Predictors of mortality and morbidity in critically ill COVID‐19 patients: An experience from a low mortality country.
- Published in:
- Health Science Reports, 2022, v. 5, n. 3, p. 1, doi. 10.1002/hsr2.542
- By:
- Publication type:
- Article
Development and Characterization of Gentamicin-Loaded Arabinoxylan-Sodium Alginate Films as Antibacterial Wound Dressing.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 5, p. 2899, doi. 10.3390/ijms23052899
- By:
- Publication type:
- Article
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28199-7
- By:
- Publication type:
- Article
Surface-engineered liposomes for dual-drug delivery targeting strategy against methicillinresistant Staphylococcus aureus (MRSA).
- Published in:
- Asian Journal of Pharmaceutical Sciences, 2022, v. 17, n. 1, p. 102, doi. 10.1016/j.ajps.2021.11.004
- By:
- Publication type:
- Article
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experience.
- Published in:
- Journal of Global Health, 2022, v. 12, p. 1, doi. 10.7189/jogh.12.05004
- By:
- Publication type:
- Article
COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar.
- Published in:
- Journal of Global Health, 2022, v. 12, p. 1, doi. 10.7189/jogh.12.05032
- By:
- Publication type:
- Article
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 19, p. 1930, doi. 10.1001/jama.2021.19623
- By:
- Publication type:
- Article